Ixazomib with lenalidomide and dexamethasone for untreated multiple myeloma [ID1170]
Discontinued
Reference number: GID-TA10254
Following on from information provided to NICE by the company in May 2020 the appraisal of Ixazomib with lenalidomide and dexamethasone for untreated multiple myeloma [ID1170] was suspended from NICE’s work programme. As no further information has been received from the company the topic has been discontinued.